In vivo, subcutaneous injection of these tumour cells in nude mice produced similar results, i.e., 35–40% reduction of tumour development upon PEAK2 depletion, as evaluated on the volume and the mass of the tumours (Figure 3B,C). Here, PRAG1 is linked to neoplasm.